SBRT for Oligoprogressive Disease, Defining Low-Risk Breast Cancer, Oral Probiotics, and Ultrasound Axillary Lymph Node Staging for Breast Cancer
Practical Radiation Oncology · 2024
DOI: 10.1016/j.prro.2024.02.002 ↗Kurz gefasst
Editorial in der Zeitschrift Practical Radiation Oncology, 2024. Verfasst von Laura Dover und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Ascension St. Vincent's East, Birmingham, Alabama. Electronic address: QuadShotNews@gmail.com. Hauptthemen laut MEDLINE: Breast Neoplasms, Radiosurgery. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Ascension St. Vincent's East, Birmingham, Alabama. Electronic address: QuadShotNews@gmail.com.
- Department of Radiation Oncology, Anderson Regional Health System, Meridian, Mississippi. Electronic address: cdulaney@andersonregional.org.
Zitieren
APA
Dover, L., & Dulaney, C. (2024). SBRT for Oligoprogressive Disease, Defining Low-Risk Breast Cancer, Oral Probiotics, and Ultrasound Axillary Lymph Node Staging for Breast Cancer. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2024.02.002
Vancouver
Dover L, Dulaney C. SBRT for Oligoprogressive Disease, Defining Low-Risk Breast Cancer, Oral Probiotics, and Ultrasound Axillary Lymph Node Staging for Breast Cancer. Practical Radiation Oncology. 2024. doi:10.1016/j.prro.2024.02.002
BibTeX
@article{Dover2024,
author = {Dover, Laura and Dulaney, Caleb},
title = {SBRT for Oligoprogressive Disease, Defining Low-Risk Breast Cancer, Oral Probiotics, and Ultrasound Axillary Lymph Node Staging for Breast Cancer},
journal = {Practical Radiation Oncology},
year = {2024},
doi = {10.1016/j.prro.2024.02.002}
}
EUVIMED